Hargreaves Lansdown investors are buying this FTSE 100 stock. Is that a smart move?

Hargreaves Lansdown investors appear to be betting that Pfizer’s coronavirus vaccine will send the share price of this FTSE 100 stock higher.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK investors have been piling into Hargreaves Lansdown (LSE: HL) shares recently. Last week, the FTSE 100 stock was the fourth most bought share on the Hargreaves Lansdown platform. Investors appear to be betting that the Pfizer vaccine will send the UK stock market, and Hargreaves’ profits, higher.

Is investing in Hargreaves Lansdown shares a smart move for me today? Let’s take a look at the investment case.

Hargreaves Lansdown: coronavirus resilience 

While other FTSE 100 companies have struggled this year, Hargreaves has performed well. For example, in August, the company posted a 15% increase in revenue and a 24% increase in profit before tax for the 12 months ended 30 June.

More recently, in October, the group said revenue for the three months to the end of September was up 12% on the same period last year. There are not many companies in the FTSE 100 delivering performances like this at the moment.

Strong financials

Taking a closer look at Hargreaves Lansdown’s financials, there’s a lot to like. Starting with profitability, this is very high. Over the last three years, return on capital employed (ROCE) has averaged 68%. This means that Hargreaves makes a big return on every pound invested in the business.

Moving on to the balance sheet, this also looks excellent. The FTSE 100 company has minimal debt, which means it’s likely to be less vulnerable during challenging periods.

Hargreaves also has a strong dividend track record. Over the last 10 years, the company has lifted its payout from 11.9p to 37.5p per share. Meanwhile, it’s paid a special dividend in four out of the last five years. While most FTSE 100 companies suspended or cancelled their dividends this year, Hargreaves raised its payout by 11% and paid out a huge special dividend. That says something about the quality of the company.

Competitive advantages

What about competitive advantages? Does Hargreaves Lansdown have an edge over the competition?

In my view, the company has several competitive advantages. Firstly, there’s its size and market share. At 30 September, it had assets under administration (AUA) of £107bn. That makes it more than twice as big as rival AJ Bell, which had AUA of £49.7bn. Its market share of the UK execution-only market is about 40%.

Hargreaves Lansdown

Source: Hargreaves Lansdown

Secondly, there’s Hargreaves’ platform itself. I think it’s brilliant. It’s very easy to use and the range of investment options is phenomenal. Customer service is also fantastic. 

Finally, the nature of the business provides a competitive advantage. Once set up on Hargreaves, it isn’t easy to switch to another provider.

Valuation and yield

Turning to the valuation, Hargreaves shares currently trade on a forward-looking P/E ratio of about 30 and sport a prospective yield of 2.6%. This means the stock isn’t a bargain. However, the share price is currently about 33% below its 2019 high, which suggests there’s upside potential.

I’d buy Hargreaves Lansdown shares 

Weighing everything up, I see a lot of appeal in Hargreaves Lansdown shares right now.

The stock isn’t without risk, of course. Competition from the likes of Vanguard is one that comes to mind. The lofty valuation is another.

However, overall, I see HL as a high-quality stock with the potential to rise higher in the long run. I’d buy this FTSE 100 share today.

Edward Sheldon owns shares in Hargreaves Lansdown. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »